We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.

Corporate Profile

Prelude is a clinical-stage biopharmaceutical company designing and developing a pipeline of novel, orally bioavailable, small molecule therapies that target key drivers of cancer cell growth, survival and resistance.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest News